A roadmap for robotic-assisted sigmoid resection in diverticular disease using a Senhance™ Surgical Robotic System: results and technical aspects

Huang

Robotics Computer Surgery

et al. 2020

Background We present our initial single‐centre experience with Senhance surgical robot‐assisted colorectal surgery and examine its safety and feasibility. Methods From June 2019 to December 2019, patients who underwent Senhance surgical robot‐assisted colorectal surgery in our hospital were retrospectively analysed. We focused on the short‐term outcomes. Results In total, 46 patients were enrolled in the study. Colorectal cancer was the most common indication for surgery (39 patients). The median total operation time was 283 min, and the median blood loss was 50 cc. Meanwhile, the median number of harvested lymph nodes was 20. Elderly age, advanced American Society of Anaesthesiologists stage, and right‐sided colon surgery were associated with the occurrence of complications greater than grade III. Conclusion Our findings demonstrate the feasibility and safety of the Senhance surgical robotic system in colorectal surgery. Care should be taken regarding the indications and patient selection.

Section: Resultsmentioning

confidence: 97%

“…7 There were some technical issues in the Senhance surgical robotic system. 17 The Senhance robotic system indicated 'exceeding force' when the manipulator arm detected excessive resistance. It is one of the features provided by the system for safety.…”

Section: Resultsmentioning

confidence: 99%

An early experience with the Senhance surgical robotic system in colorectal surgery: a single‐institute study

Huang

Robotics Computer Surgery

et al. 2020

“…Außerdem besteht in Verbin-▶ Tab. [103]. In Seoul wurde Revo I (Meerecompany) entwickelt: das inzwischen klinisch exklusiv in Korea eingesetzte System ähnelt stark den Da Vinci-Systemen [104].…”

Section: Da Vinci XI -State-of-the-artunclassified

50 Jahre Minimal-invasive Chirurgie in der Urologie

et al. 2019

ZusammenfassungDie Entwicklung der Minimal-invasiven Chirurgie (MIC) in der Urologie umfasst die Teilbereiche transurethrale Techniken, Endourologie und Extrakorporale Stosswellenlithotripsie, Uroradiologie sowie Laparoskopie und Robotische Chirurgie. Basierend auf persönlichen Erfahrungen mit der Entwicklung minimal-invasiver Verfahren seit Ende der 70iger Jahren präsentieren wir eine historische Analyse der Literatur mit dem Ziel, die wesentlichen Meilensteine der Minimal-Invasiven Therapie in der Urologie herauszuarbeiten.Motor der rasanten Entwicklung der MIC in der Urologie war die Einführung der digitalen Videotechnologie, Lasertechnologie, Fortschritte der Elektrochirurgie begleitet von den Glanzleistungen vor allem Deutscher Technologiefirmen mit zunehmender Miniaturisierung des Instrumentariums. Bedeutsam war auch die gute Kooperation zwischen Urologen, Ingenieuren und Radiologen.Die Laparoskopie wird trotz zahlreicher Weiterentwicklungen (3D-Prismentechnolgie, ETHOS-chair) zunehmend von der Robotik ersetzt. Auf Grund der auslaufendenden Patenten von Intuitive Surgical existiert seit diesem Jahr eine Konkurrenzsituation mit neuen Herstellern von Operationsrobotern. Allerdings müssen diese erst belegen, ob sie den hohen Qualitätsstandard der aktuellen Da Vinci-serie bieten können. Robotersysteme für die Endourologie werden zukünftig eine Rolle spielen, wie Avicenna RoboflexR für die flexible Ureteroskopie und AquaBeamR- für die roboter-assistierte Aquaablation der Prostata. Während RoboflexR ähnlich dem Da Vinci-system die Ergonomie des Eingriffes erleichtert, ersetzt die robotergestützte Aquablation erstmals den Operateur.

“…Expert surgeons using both techniques have reported impressive outcomes compared with standard surgeries [2]. Colectomies using this system were first reported by Spinelli [3] in 2017, and 83 cases have been reported so far [3][4][5][6][7][8][9][10][11][12][13][14]. Although some reports using CME with CVLs or D3 dissections to treat right-sided colon cancer with the Da Vinci Surgical System (Intuitive Surgical Sunnyvale, CA, USA) were found, no reports that performed D3 lymph node dissection and vascular ligation intraperitoneally by using Senhance robotic systems.…”

Section: Introductionmentioning

confidence: 99%

Right hemicolectomy with D3 lymph node dissection for right-sided transverse colon cancer using the Senhance robotic system: a case report

et al. 2020

Background The evolution of remote systems and artificial intelligence technology has led to increase in robotic surgeries. One system used in this case report is the Senhance robotic system. The most important premise for using robotic surgery in cancer therapeutics is to ensure oncological safety. Similar to conventional laparoscopic surgery, robotic surgery needs to be a reliable and secure surgical procedure, such as complete mesocolic excisions with central vascular ligations in Western countries or D3 lymph node dissections (dissection of the lymph nodes that locates from the origin to the terminal branch of the main feeding artery of cancer) in Japan. Case presentation A 76-year-old man underwent clinical examination for severe anemia. He was diagnosed with transverse colon cancer of tumor (T)3, node (N)1a, metastasis (M)0 cancer stage IIIA. A right hemicolectomy with D3 lymph node dissection using the Senhance surgical system was performed. The operative time was 313 min and the estimated blood loss was 5 ml. He was discharged from our hospital 12 days after the surgery without any complications. What is the remarkable of this report, not only mobilization of right colon but also D3 lymph node dissection and vascular ligation were performed intraperitoneally by using Senhance robotic system as conventional laparoscopic surgery. We tried using fourth robotic arm to accomplish lymphadenectomies and middle colic artery dissection. A right hemicolectomy with D3 dissection using the Da Vinci surgical system was reported. Another report of a right hemicolectomy performed with the Senhance robotic system was identified; however, in that study, lymph node dissections were not performed intraperitoneally. Conclusions Therefore, to our knowledge, this is the first report using the Senhance robotic system for right hemicolectomy with D3 dissection. We hope that our case report will assist in the establishment of this robotic procedure in surgical practice.